Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study.
Egsmose C, Lund B, Borg G, Pettersson H, Berg E, Brodin U, Trang L. Egsmose C, et al. Among authors: borg g. J Rheumatol. 1995 Dec;22(12):2208-13. J Rheumatol. 1995. PMID: 8835550 Clinical Trial.

METHODS: One hundred thirty-seven patients with RA of < 2 years' duration entered a double blind placebo controlled study: patients in the "early" (E) group were treated with auranofin within one year of diagnosis of RA, and SAARD treatment in the initially placebo treated gro

METHODS: One hundred thirty-seven patients with RA of < 2 years' duration entered a double blind placebo controlled study: patients in th

81 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page